CVM CEL-SCI Corp

USD 1.91 0.02 1.058201
Icon

CEL-SCI Corp (CVM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.91

+0.02 (+1.06)%

USD 0.11B

0.10M

N/A

N/A

Icon

CVM

CEL-SCI Corp (USD)
COMMON STOCK | NYE
USD 1.91
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.11B

N/A

USD 1.91

CEL-SCI Corp (CVM) Stock Forecast

N/A

Based on the CEL-SCI Corp stock forecast from 0 analysts, the average analyst target price for CEL-SCI Corp is not available over the next 12 months. CEL-SCI Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CEL-SCI Corp is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, CEL-SCI Corp’s stock price was USD 1.91. CEL-SCI Corp’s stock price has changed by +1.06% over the past week, -5.45% over the past month and -16.96% over the last year.

No recent analyst target price found for CEL-SCI Corp
No recent average analyst rating found for CEL-SCI Corp

Company Overview CEL-SCI Corp

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical t...Read More

https://cel-sci.com

8229 Boone Boulevard, Vienna, VA, United States, 22182

0

September

USD

USA

Adjusted Closing Price for CEL-SCI Corp (CVM)

Loading...

Unadjusted Closing Price for CEL-SCI Corp (CVM)

Loading...

Share Trading Volume for CEL-SCI Corp Shares

Loading...

Compare Performance of CEL-SCI Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CVM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To CEL-SCI Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S +0.35 (+0.27%) USD554.45B 46.01 4.80

ETFs Containing CVM

Symbol Name CVM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About CEL-SCI Corp (CVM) Stock

Stock Target Advisor's fundamental analysis for CEL-SCI Corp's stock is Bearish.

Unfortunately we do not have enough data on CVM's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on CVM's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on CVM's stock to indicate if its overvalued.

The last closing price of CVM's stock was USD 1.91.

The most recent market capitalization for CVM is USD 0.11B.

Unfortunately we do not have enough analyst data on CVM's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains CEL-SCI Corp's stock.

As per our most recent records CEL-SCI Corp has 0 Employees.

CEL-SCI Corp's registered address is 8229 Boone Boulevard, Vienna, VA, United States, 22182. You can get more information about it from CEL-SCI Corp's website at https://cel-sci.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...